Status:
COMPLETED
Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Eating Disorder
Eligibility:
FEMALE
18-34 years
Phase:
NA
Brief Summary
Most people with an eating disorder (ED) do not receive good treatment. The investigators have developed a new brief group treatment that is supposed to work by reducing how much women with an ED valu...
Detailed Description
Only 3-20% of individuals with eating disorders (EDs) receive treatment, and those who do rarely receive evidence-based treatments because they are very intensive and costly, few clinicians deliver th...
Eligibility Criteria
Inclusion
- DSM-5 eating disorder
- Must have a primary care doctor
Exclusion
- Non-English speakers
- BMI \<75% ideal body weight
- Current acute suicidal ideation (defined as thoughts of a specific method or plan)
- Comorbid psychiatric disorder that would disrupt groups (e.g., bipolar disorder, substance misuse)
- Serious medical problems (e.g., diabetes)
Key Trial Info
Start Date :
July 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT03261050
Start Date
July 10 2017
End Date
January 31 2025
Last Update
June 11 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305
2
Oregon Research Institute
Eugene, Oregon, United States, 97403